LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

COVID‐19 vaccine acceptance among patients with glomerulonephritis

Photo from wikipedia

kidney biopsy was M1E1S1T1C2. The patient underwent tonsillectomy and steroid pulse therapy. After 35 days of treatment, serum Cre levels improved to 2.74 mg/dl and proteinuria decreased to 0.2 g/gCre.… Click to show full abstract

kidney biopsy was M1E1S1T1C2. The patient underwent tonsillectomy and steroid pulse therapy. After 35 days of treatment, serum Cre levels improved to 2.74 mg/dl and proteinuria decreased to 0.2 g/gCre. Many studies have reported recurrence or worsening of various kidney diseases after SARS-CoV-2 infection. Considering the absence of prior urinary abnormalities, he seemingly developed new kidney damage within few months, indicating rapidly progressive glomerulonephritis. To our knowledge, this is the first case report describing the clinical course of new-onset IgA nephropathy due to SARS-CoV-2 infection. The mechanism of IgA nephropathy post SARS-CoV-2 infection remains to be elucidated; however, continuous IgA production after SARSCoV-2 infection may occur. There is a possibility of developing new nephritis as well as exacerbation of existing nephritis after SARS-CoV-2 infection, necessitating a careful follow-up.

Keywords: infection; acceptance among; vaccine acceptance; covid vaccine; cov infection; sars cov

Journal Title: Nephrology
Year Published: 2022

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.